Filing metadata

Accession number
0001562180-23-005953
Form type
Form 3
Filer
Akebia Therapeutics, Inc.
CIK
CIK 1517022
Filed
Jul 18, 2023
Reporting period
Jul 10, 2023
Description
Initial ownership

Explore SEC Filings Hub